<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>19</Volume>
				<Issue>9</Issue>
				<PubDate PubStatus="epublish">
					<Year>2018</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Involvement of microRNA-423 Gene Variability in Breast Cancer Progression in Saudi Arabia</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2581</FirstPage>
			<LastPage>2589</LastPage>
			<ELocationID EIdType="pii">66655</ELocationID>
			
<ELocationID EIdType="doi">10.22034/APJCP.2018.19.9.2581</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>R </FirstName>
					<LastName>Mir</LastName>
<Affiliation>Department of Medical Lab Technology, Prince Fahd Bin Sultan Research Chair, Faculty of Applied Medical Sciences,University of Tabuk, Tabuk, Kingdom of Saudi Arabia.</Affiliation>

</Author>
<Author>
					<FirstName>I A </FirstName>
					<LastName>Al Balawi</LastName>
<Affiliation>Department of Surgical Oncology, Faculty of Medicine University of Tabuk, Tabuk, Kingdom of Saudi Arabia.</Affiliation>
<Identifier Source="ORCID">0000-0002-2952-9501</Identifier>

</Author>
<Author>
					<FirstName>F M </FirstName>
					<LastName>Abu Duhier</LastName>
<Affiliation>Department of Medical Lab Technology, Prince Fahd Bin Sultan Research Chair, Faculty of Applied Medical Sciences,University of Tabuk, Tabuk, Kingdom of Saudi Arabia.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2018</Year>
					<Month>04</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>Aim: microRNA-423 is an oncogenic factor which is frequently upregulated in cancer. However, associations with&lt;br /&gt;breast cancer risk remain inconsistent. Therefore, we investigated the prevalence of microRNA-423 rs6505162C&gt;T&lt;br /&gt;gene variation with breast cancer susceptibility in Saudi women. Methodology: This study was conducted on 100&lt;br /&gt;breast cancer patients and 124 matched healthy individuals. Genotyping of the microRNA-423 rs6505162C/T gene&lt;br /&gt;variation was performed by using the amplification refractory mutation system PCR method (ARMS-PCR). Results:&lt;br /&gt;A significant difference was observed in the genotype distribution between the breast cancer cases and controls&lt;br /&gt;(p=0.0001), the frequencies of the genotypes CC,CT and TT being 25%, 52% and 23% in patients and 65%,20% and&lt;br /&gt;15% respectively, in controls. The microRNA-423 C&gt;T variant was associated with an increased risk of breast cancer&lt;br /&gt;in codominant models for (OR = 6.73, 95 % CI, 3.50-12.97; RR 2.35(1.67-3.30, p=0.0001) the microRNA-423TT&lt;br /&gt;genotype and (OR = 4.14, 95 % CI, 1.93-8.87; p=0.0003) microRNA-423CT (OR= 6.73, 95% CI, 3.50-12.97; p=0.0001)&lt;br /&gt;and also with the dominant model (OR 5.6(3.14-1.01), p=0.0001) CT+TT vs CC) with a non-significant association for&lt;br /&gt;the recessive model (OR=1.75, 95%CI=0.08-3.44, P=0.139, TT vs CC+CT). The T allele significantly increased the&lt;br /&gt;risk of breast cancer (OR =2.63, 95 % CI, 1.77-3.91; p=0.001) compared to the C allele. Some 6.73 ,4.14 and 2.63 fold&lt;br /&gt;increased risk of developing breast cancer was associated with TT and CT genotypes and the T allele of microRNA-423&lt;br /&gt;in the northwestern region of Saudi Arabia. Conclusion: Our findings indicate that the microRNA-423 TT genotype&lt;br /&gt;and the T allele are associated with an increased susceptibility, metastasis and advanced stage of breast cancer in Saudi&lt;br /&gt;Arabian patients. Further studies with larger sample sizes are necessary to confirm our findings.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">microRNA-423</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">SNP- Single-nucleotide polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ARMS-Amplification refractory mutation system</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">OR-Odds ratio</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">CI-Confidence interval</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_66655_c9bba32c587d227301810257e7b17ca2.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
